Rose Sharon Shabet, 10% Owner at 4D Molecular Therapeutics, Inc. (FDMT), bought 850,000 shares at $16.00 ($13.6M) on 2023-05-09, disclosed to the SEC on 2023-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | BUY | 2019-06-28 | $80.0M | — | Filing → |
| UROV | BUY | 2019-06-14 | $177K | — | Filing → |